TITLE

RU 486: The politics of choice

AUTHOR(S)
Stulac, Francine
PUB. DATE
March 1991
SOURCE
Health Matrix: Journal of Law-Medicine;Spring91, Vol. 1 Issue 1, p77
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the controversy concerning the drug RU-486 or mifepristone which used for the termination of pregnancy. Description of the drug; Details of the social controversy concerning the drug; Discussion on the approval process of the US Food and Drug Administration; Potential application of the process on RU-486; Impact of politics on the drug's introduction.
ACCESSION #
9701222516

 

Related Articles

  • Linking choice with AIDS.  // Hastings Center Report;Jul/Aug90, Vol. 20 Issue 4, p4 

    Relates, in a reprint from The Washington Post, that a law passed in 1987 may aid in getting RU-486 into the United States for study. Testing of experimental drugs; The California Food and Drug Branch; Testing of AIDS vaccines.

  • Pill politics. Fraser, L. // Mother Jones;Jun88, Vol. 13 Issue 4, p30 

    A new pill, an antiprogesterone steroid called RU486, can end a pregnancy up to three weeks after a missed menstrual period. Extensive research has shown it safe enough to be a breakthrough for women with unwanted pregnancies. While it has been approved for use in five countries, political...

  • RU-486 abortion procedure funded by French government.  // Women's International Network News;Spring90, Vol. 16 Issue 2, p31 

    Reports on France's decision to cover RU-486 expenses under the National Health Plan of the Government. Background information on the drug RU-486; Cost of the abortion procedure.

  • Large study confirms safety of RU-486 French abortion pill.  // Women's International Network News;Spring90, Vol. 16 Issue 2, p32 

    Reports on the results of a study confirming the safety of the RU-486 abortion pill. Availability; Hesitation to bring the drug to the United States; Health risks.

  • Battle over the abortion pill.  // Newsweek;11/7/1988, Vol. 112 Issue 19, p10 

    Report that the controversial Roussel-Uclaf RU 486 abortion pill was removed from the world market shortly after its approval by the French government. Following an outcry from doctors, population experts and feminists world-wide, the pill was redistributed. Controversy.

  • Abortion in the form of a pill. Seligmann, J.; Hager, M. // Newsweek;4/17/1989, Vol. 113 Issue 16, p61 

    Discusses the controversy over manufacturer Roussel-Uclaf's `abortion pill,' the RU 486, developed by Etienne-Emile Baulieu in France. Approved for sale in France and China, the pill blocks the action of progesterone and expels the fertilized egg. The pill is not painless and must be used...

  • RU 486. Fraser, L. // Glamour;Sep90, Vol. 88 Issue 9, p316 

    Describes the drug RU 486, a new `abortion pill' developed in France. It has been highly successful in terminating pregnancies without surgery when taken within a month after a missed period. French and United States studies and findings; How drug works; Opposition to drug; Benefits over...

  • Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital... Glasier, Anna; Thong, K.J. // New England Journal of Medicine;10/8/92, Vol. 327 Issue 15, p1041 

    Tests the use of mifepristone for emergency postcoital contraception. RU 486 is a synthetic steroid with potent antiporgestational and antiglucocorticoid properties; Study of 800 women and adolescents requesting emergency postcoital contraception; Conclusion that mifepristone is a highly...

  • Reproduction showdown. Schrof, Joannie M. // U.S. News & World Report;3/22/93, Vol. 114 Issue 11, p32 

    Discusses advocates' predictions that the French abortion pill, RU-486, will revolutionize women's health. Background on RU-486; Arguments by opponents and advocates; The health benefits that RU-486 has shown; The availability of the abortion pill; How it works to cause abortion of a fetus;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics